Testing a MultiTEP-based combination vaccine to reduce Aβ and tau pathology in Tau22/5xFAD bigenic mice

BACKGROUND: Alzheimer disease (AD) is characterized by the accumulation of beta-amyloid (Aβ) plaques and neurofibrillary tangles composed of hyperphosphorylated tau, which together lead to neurodegeneration and cognitive decline. Current therapeutic approaches have primarily aimed to reduce patholog...

Descripción completa

Detalles Bibliográficos
Autores principales: Davtyan, Hayk, Hovakimyan, Armine, Kiani Shabestari, Sepideh, Antonyan, Tatevik, Coburn, Morgan A., Zagorski, Karen, Chailyan, Gor, Petrushina, Irina, Svystun, Olga, Danhash, Emma, Petrovsky, Nikolai, Cribbs, David H., Agadjanyan, Michael G., Blurton-Jones, Mathew, Ghochikyan, Anahit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6918571/
https://www.ncbi.nlm.nih.gov/pubmed/31847886
http://dx.doi.org/10.1186/s13195-019-0556-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6918571/
https://www.ncbi.nlm.nih.gov/pubmed/31847886
http://dx.doi.org/10.1186/s13195-019-0556-2

Ejemplares similares